The SARS-CoV S glycoprotein View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2004-10

AUTHORS

X. Xiao, D. S. Dimitrov

ABSTRACT

The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors. More... »

PAGES

2428-2430

References to SciGraph publications

  • 2004-02. Virus entry: molecular mechanisms and biomedical applications in NATURE REVIEWS MICROBIOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00018-004-4257-y

    DOI

    http://dx.doi.org/10.1007/s00018-004-4257-y

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1008954920

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/15526150


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biochemistry and Cell Biology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Fusion", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Membrane Glycoproteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Structure, Tertiary", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "SARS Virus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Spike Glycoprotein, Coronavirus", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Viral Envelope Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Viral Fusion Proteins", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201 USA", 
              "id": "http://www.grid.ac/institutes/grid.429651.d", 
              "name": [
                "Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Xiao", 
            "givenName": "X.", 
            "id": "sg:person.0675260434.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675260434.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201 USA", 
              "id": "http://www.grid.ac/institutes/grid.429651.d", 
              "name": [
                "Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201 USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dimitrov", 
            "givenName": "D. S.", 
            "id": "sg:person.012247636637.59", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012247636637.59"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrmicro817", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1044058158", 
              "https://doi.org/10.1038/nrmicro817"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2004-10", 
        "datePublishedReg": "2004-10-01", 
        "description": "The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00018-004-4257-y", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2710305", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1295005", 
            "issn": [
              "1420-682X", 
              "1420-9071"
            ], 
            "name": "Cellular and Molecular Life Sciences", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "19", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "61"
          }
        ], 
        "keywords": [
          "entry inhibitors", 
          "SARS-CoV S glycoprotein", 
          "candidate vaccine immunogens", 
          "vaccine immunogens", 
          "virus entry", 
          "major immunogen", 
          "immunogen", 
          "inhibitors", 
          "cell fusion", 
          "glycoprotein", 
          "membrane fusion", 
          "target", 
          "fusion", 
          "protein", 
          "spikes", 
          "recent rapid advances", 
          "entry", 
          "rapid advances", 
          "advances", 
          "function", 
          "development", 
          "number", 
          "knowledge", 
          "structure", 
          "severe acute respiratory syndrome-coronavirus (SARS-CoV) spike", 
          "acute respiratory syndrome-coronavirus (SARS-CoV) spike", 
          "respiratory syndrome-coronavirus (SARS-CoV) spike", 
          "syndrome-coronavirus (SARS-CoV) spike", 
          "SARS-CoV entry inhibitors", 
          "S glycoprotein"
        ], 
        "name": "The SARS-CoV S glycoprotein", 
        "pagination": "2428-2430", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1008954920"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00018-004-4257-y"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "15526150"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00018-004-4257-y", 
          "https://app.dimensions.ai/details/publication/pub.1008954920"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:16", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_388.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00018-004-4257-y"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00018-004-4257-y'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00018-004-4257-y'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00018-004-4257-y'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00018-004-4257-y'


     

    This table displays all metadata directly associated to this object as RDF triples.

    145 TRIPLES      22 PREDICATES      68 URIs      59 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00018-004-4257-y schema:about N01f8e5e1548d469eb36f0331ce83bbb0
    2 N16ca33db6a384bee99bf0333a2349881
    3 N21073635745d4306add2d869a83f66a2
    4 N5875bb42fc68425e868b6cddc7e57102
    5 N779a2698238f4bb780cabd1c67214b48
    6 N96ca4ea80d6541dbb865bf941e72e174
    7 Nac6cc81f0ffb46819b16c01d06967f3a
    8 Nbc806820f0034bfab5f3b424271927ac
    9 Ncd5f72986f794325b874e77df99c0e04
    10 Ne1471ee0f1b14e4a856511654d0976d0
    11 anzsrc-for:06
    12 anzsrc-for:0601
    13 schema:author N1c60e80b4d5a4304b1c276b329bcc07c
    14 schema:citation sg:pub.10.1038/nrmicro817
    15 schema:datePublished 2004-10
    16 schema:datePublishedReg 2004-10-01
    17 schema:description The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors.
    18 schema:genre article
    19 schema:inLanguage en
    20 schema:isAccessibleForFree true
    21 schema:isPartOf Ndcdb8a7450664640b8e2f956bcf25294
    22 Nf1c5a0d3acb34ee0b78471056c06d34b
    23 sg:journal.1295005
    24 schema:keywords S glycoprotein
    25 SARS-CoV S glycoprotein
    26 SARS-CoV entry inhibitors
    27 acute respiratory syndrome-coronavirus (SARS-CoV) spike
    28 advances
    29 candidate vaccine immunogens
    30 cell fusion
    31 development
    32 entry
    33 entry inhibitors
    34 function
    35 fusion
    36 glycoprotein
    37 immunogen
    38 inhibitors
    39 knowledge
    40 major immunogen
    41 membrane fusion
    42 number
    43 protein
    44 rapid advances
    45 recent rapid advances
    46 respiratory syndrome-coronavirus (SARS-CoV) spike
    47 severe acute respiratory syndrome-coronavirus (SARS-CoV) spike
    48 spikes
    49 structure
    50 syndrome-coronavirus (SARS-CoV) spike
    51 target
    52 vaccine immunogens
    53 virus entry
    54 schema:name The SARS-CoV S glycoprotein
    55 schema:pagination 2428-2430
    56 schema:productId N1dc16183329c44e4a83fff1b9e28a56a
    57 N82a13bb2b781409b99dbecef974d5608
    58 Nceffd176c6e84879a64da7c98f4b5e98
    59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008954920
    60 https://doi.org/10.1007/s00018-004-4257-y
    61 schema:sdDatePublished 2021-12-01T19:16
    62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    63 schema:sdPublisher N8b1ead0bf9704235b55c0faa1da78c5d
    64 schema:url https://doi.org/10.1007/s00018-004-4257-y
    65 sgo:license sg:explorer/license/
    66 sgo:sdDataset articles
    67 rdf:type schema:ScholarlyArticle
    68 N01f8e5e1548d469eb36f0331ce83bbb0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    69 schema:name Spike Glycoprotein, Coronavirus
    70 rdf:type schema:DefinedTerm
    71 N16ca33db6a384bee99bf0333a2349881 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    72 schema:name Cell Fusion
    73 rdf:type schema:DefinedTerm
    74 N1c60e80b4d5a4304b1c276b329bcc07c rdf:first sg:person.0675260434.36
    75 rdf:rest N4beb82d3c49140048d9395e49753475e
    76 N1dc16183329c44e4a83fff1b9e28a56a schema:name pubmed_id
    77 schema:value 15526150
    78 rdf:type schema:PropertyValue
    79 N21073635745d4306add2d869a83f66a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    80 schema:name Viral Envelope Proteins
    81 rdf:type schema:DefinedTerm
    82 N4beb82d3c49140048d9395e49753475e rdf:first sg:person.012247636637.59
    83 rdf:rest rdf:nil
    84 N5875bb42fc68425e868b6cddc7e57102 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    85 schema:name Protein Structure, Tertiary
    86 rdf:type schema:DefinedTerm
    87 N779a2698238f4bb780cabd1c67214b48 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    88 schema:name Animals
    89 rdf:type schema:DefinedTerm
    90 N82a13bb2b781409b99dbecef974d5608 schema:name dimensions_id
    91 schema:value pub.1008954920
    92 rdf:type schema:PropertyValue
    93 N8b1ead0bf9704235b55c0faa1da78c5d schema:name Springer Nature - SN SciGraph project
    94 rdf:type schema:Organization
    95 N96ca4ea80d6541dbb865bf941e72e174 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    96 schema:name SARS Virus
    97 rdf:type schema:DefinedTerm
    98 Nac6cc81f0ffb46819b16c01d06967f3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    99 schema:name Membrane Glycoproteins
    100 rdf:type schema:DefinedTerm
    101 Nbc806820f0034bfab5f3b424271927ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Glycoproteins
    103 rdf:type schema:DefinedTerm
    104 Ncd5f72986f794325b874e77df99c0e04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    105 schema:name Viral Fusion Proteins
    106 rdf:type schema:DefinedTerm
    107 Nceffd176c6e84879a64da7c98f4b5e98 schema:name doi
    108 schema:value 10.1007/s00018-004-4257-y
    109 rdf:type schema:PropertyValue
    110 Ndcdb8a7450664640b8e2f956bcf25294 schema:volumeNumber 61
    111 rdf:type schema:PublicationVolume
    112 Ne1471ee0f1b14e4a856511654d0976d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Humans
    114 rdf:type schema:DefinedTerm
    115 Nf1c5a0d3acb34ee0b78471056c06d34b schema:issueNumber 19
    116 rdf:type schema:PublicationIssue
    117 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    118 schema:name Biological Sciences
    119 rdf:type schema:DefinedTerm
    120 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
    121 schema:name Biochemistry and Cell Biology
    122 rdf:type schema:DefinedTerm
    123 sg:grant.2710305 http://pending.schema.org/fundedItem sg:pub.10.1007/s00018-004-4257-y
    124 rdf:type schema:MonetaryGrant
    125 sg:journal.1295005 schema:issn 1420-682X
    126 1420-9071
    127 schema:name Cellular and Molecular Life Sciences
    128 schema:publisher Springer Nature
    129 rdf:type schema:Periodical
    130 sg:person.012247636637.59 schema:affiliation grid-institutes:grid.429651.d
    131 schema:familyName Dimitrov
    132 schema:givenName D. S.
    133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012247636637.59
    134 rdf:type schema:Person
    135 sg:person.0675260434.36 schema:affiliation grid-institutes:grid.429651.d
    136 schema:familyName Xiao
    137 schema:givenName X.
    138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675260434.36
    139 rdf:type schema:Person
    140 sg:pub.10.1038/nrmicro817 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044058158
    141 https://doi.org/10.1038/nrmicro817
    142 rdf:type schema:CreativeWork
    143 grid-institutes:grid.429651.d schema:alternateName Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201 USA
    144 schema:name Protein Interactions Group, LECB, CCR, NCI-Frederick, NIH, Building 469, Room 105, Frederick, Maryland 21702-1201 USA
    145 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...